Characteristics |
Univariate analysis |
Multivariate analysis |
|||
| Hazard ratio (95% CI) | P value | Hazard ratio (95% CI) | P value | ||
| Age | |||||
| <=60 | Reference | ||||
| >60 | 1.205 (0.850-1.708) | 0.295 | |||
| Gender | |||||
| Female | Reference | ||||
| Male | 0.793 (0.557-1.130) | 0.200 | |||
| Race | |||||
| Black or African American & White | Reference | ||||
| Asian | 0.746 (0.515-1.080) | 0.121 | |||
| Tumor status | |||||
| Tumor free | Reference | ||||
| With tumor | 2.317 (1.590-3.376) | <0.001 | 2.086 (1.310-3.322) | 0.002 | |
| Histologic grade | |||||
| G1 & G2 | Reference | ||||
| G3 & G4 | 1.091 (0.761-1.564) | 0.636 | |||
| Pathologic stage | |||||
| Stage I & Stage II | Reference | ||||
| Stage III & Stage IV | 2.504 (1.727-3.631) | <0.001 | 1.401 (0.190-10.316) | 0.741 | |
| T stage | |||||
| T1 & T2 | Reference | ||||
| T3 & T4 | 2.598 (1.826-3.697) | <0.001 | 1.707 (0.231-12.615) | 0.600 | |
| N stage | |||||
| N0 | Reference | ||||
| N1 | 2.029 (0.497-8.281) | 0.324 | |||
| M stage | |||||
| M0 | Reference | ||||
| M1 | 4.077 (1.281-12.973) | 0.017 | 1.353 (0.322-5.689) | 0.680 | |
| EFNA3 | |||||
| Low | Reference | ||||
| High | 1.609 (1.136-2.280) | 0.007 | 1.606 (1.018-2.534) | 0.042 | |